Global assessment of treatment success · people with impingement syndrome without full‐thickness rotator cuff tears
Subacromial decompression showed no clear difference in global assessment of treatment success compared with placebo surgery (moderate certainty).
1 finding from 1 review
Health status and quality of life · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
Adverse events · people with impingement syndrome without full‐thickness rotator cuff tears
Subacromial decompression showed no clear difference in adverse events compared with placebo surgery (moderate certainty).
1 finding from 1 review
Serious adverse events · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
Paina (scale from 0‐10, 0 is no pain) · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
Functional outcomes · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
Global assessment of treatment success · people with impingement syndrome without full‐thickness rotator cuff tears
Subacromial decompression showed no clear difference in global assessment of treatment success compared with exercises (low certainty).
1 finding from 1 review
All‐cause mortality · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Quality of life Drug resistance/microbial sensitivity Serious adverse events Lung function Hospitalisations Adverse events/side effects Number of participants colonised with P aeruginosa · patients with chronic obstructive pulmonary disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Deaths · any indication
Other adverse events in people taking macrolide antibiotics showed no clear difference in deaths compared with placebo (low certainty).
1 finding from 1 review
Cardiac disorders · any indication
It is very uncertain whether other adverse events in people taking macrolide antibiotics changes cardiac disorders compared with placebo (very low certainty).
1 finding from 1 review
Hearing loss · any indication
Other adverse events in people taking macrolide antibiotics showed no clear difference in hearing loss compared with placebo (low certainty).
1 finding from 1 review
Taste disturbance · any indication
Other adverse events in people taking macrolide antibiotics may leads to higher taste disturbance compared with placebo (low certainty).
1 finding from 1 review
Hepatobiliary disorders · any indication
It is very uncertain whether other adverse events in people taking macrolide antibiotics changes hepatobiliary disorders compared with placebo (very low certainty).
1 finding from 1 review
Resolution of symptoms post‐treatment (ITT analysis) · group A streptococcal pharyngitis
Macrolides showed no clear difference in resolution of symptoms post‐treatment (ITT analysis) compared with penicillin (low certainty).
1 finding from 1 review
Resolution of symptoms post‐treatment (evaluable participants) · group A streptococcal pharyngitis
Macrolides showed no clear difference in resolution of symptoms post‐treatment (evaluable participants) compared with penicillin (low certainty).
1 finding from 1 review
Relapse · group A streptococcal pharyngitis
Macrolides showed no clear difference in incidence of relapse (evaluable participants) compared with penicillin (low certainty).
1 finding from 1 review
Adverse events (ITT analysis) · group A streptococcal pharyngitis
Macrolides showed no clear difference in adverse events (ITT analysis) compared with penicillin (low certainty).
1 finding from 1 review
Complete remission (no further aphthous episodes to 6 months) · idiopathic steroid‐resistant nephrotic syndrome in children
Tacrolimus showed no clear difference in treatment response at 6 months: complete remission compared with cyclosporin (low certainty).
1 finding from 1 review
Complete or partial remission · idiopathic steroid‐resistant nephrotic syndrome in children
Tacrolimus showed no clear difference in treatment response at 6 months: complete and partial remission compared with cyclosporin (low certainty).
2 findings from 1 review